Developing oral probiotics from Streptococcus salivarius.
about
Bacteriocin production: a relatively unharnessed probiotic trait?Phenotypic diversity of multicellular filamentation in oral StreptococciProtective role of the capsule and impact of serotype 4 switching on Streptococcus mitis.The vaginal isolate Lactobacillus paracasei LPC-S01 (DSM 26760) is suitable for oral administration.Cariogram outcome after 90 days of oral treatment with Streptococcus salivarius M18 in children at high risk for dental caries: results of a randomized, controlled studyInvestigation of Streptococcus salivarius-mediated inhibition of pneumococcal adherence to pharyngeal epithelial cellsMultipronged approach for engineering novel peptide analogues of existing lantibiotics.Capsule expression in Streptococcus mitis modulates interaction with oral keratinocytes and alters susceptibility to human antimicrobial peptides.Oral flora in acute stroke patients: A prospective exploratory observational study.Role of a proprietary propolis-based product on the wait-and-see approach in acute otitis media and in preventing evolution to tracheitis, bronchitis, or rhinosinusitis from nonstreptococcal pharyngitis.Positive clinical outcomes derived from using Streptococcus salivarius K12 to prevent streptococcal pharyngotonsillitis in children: a pilot investigation.Colonization, safety, and tolerability study of the Streptococcus salivarius 24SMBc nasal spray for its application in upper respiratory tract infections.Resistance Genes and Genetic Elements Associated with Antibiotic Resistance in Clinical and Commensal Isolates of Streptococcus salivarius.New insights into the mode of action of the lantibiotic salivaricin B.Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in childrenOral use of Streptococcus salivarius K12 in children with secretory otitis media: preliminary results of a pilot, uncontrolled study.Dysbiosis of oral buccal mucosa microbiota in patients with oral lichen planus.Probiotics: A Promising Role in Dental Health.Molecular analysis of oral microflora in patients with primary Sjögren's syndrome by using high-throughput sequencing
P2860
Q28073604-F686D870-6928-49ED-B5A2-C1445BB08EE3Q28678672-96624CCB-5138-4A8E-BFDB-F0317FF56813Q34298414-E581ACB1-3755-4F21-A44E-837BF9AF0E51Q36059416-D39EFAE3-F3D2-48FA-8700-BD7D273BBCFFQ36137331-5515F7B7-0950-4620-BA47-7FD4EB059F92Q36146974-F6ADFF5B-02CA-429A-875F-034ED84A5F34Q38500614-655941F3-FDD5-4721-AB12-E4D2A2D62FCFQ38845164-1596F695-98D9-4465-AF51-4B3AC667AD10Q40198863-85D9C484-D1CC-4CBD-90DD-D31F0F7581D4Q40412476-18797306-3770-405F-9252-8438E40DD923Q40422612-A4D393C0-512A-41DF-9DB1-250A74436E00Q41092214-463DB7F5-90AC-4495-8910-9D08A1BB54AEQ41344454-7AD4783E-CCDE-4442-90BD-221DFF28B564Q41884008-F87AAFFD-7C3F-4D23-9462-CE278D3E5DC7Q41963447-6070A6A6-E339-4365-9F6A-1047EEFDDF16Q42032182-C0EAEA5A-2AC1-46A3-9BBF-494D663FD28FQ46417554-6C2969A1-97E1-4A1C-A672-51812F3004FFQ52643961-BA358F84-74FD-4670-A11D-AFCB9FAC4783Q57067550-B2FEEAEE-5BFC-45B6-B087-84DF6A6E5708
P2860
Developing oral probiotics from Streptococcus salivarius.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Developing oral probiotics from Streptococcus salivarius.
@en
type
label
Developing oral probiotics from Streptococcus salivarius.
@en
prefLabel
Developing oral probiotics from Streptococcus salivarius.
@en
P2093
P2860
P356
P1433
P1476
Developing oral probiotics from Streptococcus salivarius.
@en
P2093
John D F Hale
John R Tagg
Nicholas C K Heng
Philip A Wescombe
P2860
P304
P356
10.2217/FMB.12.113
P577
2012-12-01T00:00:00Z